Glucan particles for selective delivery of siRNA to phagocytic cells in mice. - Wikidata - wikimedia - TriplyDB

Glucan particles for selective delivery of siRNA to phagocytic cells in mice.

Glucan particles for selective delivery of siRNA to phagocytic cells in mice.

http://www.wikidata.org/entity/Q42813063

about

Identification of Map4k4 as a novel suppressor of skeletal muscle differentiation Recent advances in oral vaccine development: yeast-derived β-glucan particles Progress toward in vivo use of siRNAs-II MRI tracking of macrophages labeled with glucan particles entrapping a water insoluble paramagnetic Gd-based agent.Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes.Lipid storage by adipose tissue macrophages regulates systemic glucose tolerance Novel strategies to enhance vaccine immunity against coccidioidomycosis.Exploiting fungal cell wall components in vaccines Specifically targeted delivery of protein to phagocytic macrophages.Activated Kupffer cells inhibit insulin sensitivity in obese mice.Gene silencing in adipose tissue macrophages regulates whole-body metabolism in obese mice.Silencing CCR2 in Macrophages Alleviates Adipose Tissue Inflammation and the Associated Metabolic Syndrome in Dietary Obese Mice.Targeted Delivery of Glucan Particle Encapsulated Gallium Nanoparticles Inhibits HIV Growth in Human Macrophages.Peptide- and Amine-Modified Glucan Particles for the Delivery of Therapeutic siRNA.siRNA therapeutics in the treatment of diseases.Targeted delivery systems for biological therapies of inflammatory diseases.Glucan particles for macrophage targeted delivery of nanoparticles.Duality of β-glucan microparticles: antigen carrier and immunostimulants.Trimethyl chitosan-cysteine nanoparticles for systemic delivery of TNF-α siRNA via oral and intraperitoneal routes.Decreasing CB1 receptor signaling in Kupffer cells improves insulin sensitivity in obese mice.Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type 2 Diabetes.Beta-Glucan Particles as Vaccine Adjuvant Carriers.CRISPR-delivery particles targeting nuclear receptor-interacting protein 1 () in adipose cells to enhance energy expenditure

P2860

Q24305188-01D931AD-4D39-4605-99C1-E98945370F63 Q27001699-24201B09-9ED0-4DA6-86BF-A80CB98C05D0 Q28255877-A9A7C6BD-005E-4ED7-9291-2944FE184BFE Q30578470-4D0A6BBD-C6A7-4F81-B690-70C8E70D442B Q33731729-54F3E33B-8B8A-4B7B-AE34-902CBAA2312C Q34062793-A9C5EC19-5AD7-4B51-8906-07195F885DF4 Q35075092-FAB4135E-EA34-4D61-9726-E1B86E02A9B5 Q35085200-4D9F93F6-8EB8-495D-8338-F871361C5280 Q35168631-F13A2781-5249-426A-B3A2-AC5C42705BD9 Q35774740-2D3EE63D-580A-4F18-8C56-20E8588B48A1 Q36855257-CDB2A27A-D39A-4BED-A58E-B245AFBA050D Q37234557-F379F7CE-B7B9-4CCF-B922-A3358EABDA05 Q37443661-891E3ACF-7DEF-49D9-95D3-D01C6F6E2984 Q37498037-36CFCBE7-256E-407B-B070-B1314A60AB95 Q38074462-F30207A6-8A60-4D07-A56A-AC76E9CBC300 Q38264691-09DD39C1-568E-4FFD-AD46-61C0F0EA32A1 Q38730668-769D0C60-B459-427A-A31B-5DDC349CAFE4 Q40688473-D5362FC2-6743-4021-A9B2-C0BDB008DF30 Q46731155-711F62B6-88A5-433F-A523-EB67E2C03806 Q47149284-81238227-10A1-47EC-91A6-7830981D7BD8 Q50462161-278E9F84-A026-414E-8148-D92D98C423ED Q50957928-12D8EC2C-7433-423A-A015-595678F2C0B9 Q58760448-908A66A9-1E4A-4BAB-9C3A-0BFE1392004D

P2860

Glucan particles for selective delivery of siRNA to phagocytic cells in mice.

http://www.wikidata.org/entity/Q42813063

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Glucan particles for selective delivery of siRNA to phagocytic cells in mice.

@en

Glucan particles for selective delivery of siRNA to phagocytic cells in mice.

@nl

type

label

Glucan particles for selective delivery of siRNA to phagocytic cells in mice.

@en

Glucan particles for selective delivery of siRNA to phagocytic cells in mice.

@nl

prefLabel

Glucan particles for selective delivery of siRNA to phagocytic cells in mice.

@en

Glucan particles for selective delivery of siRNA to phagocytic cells in mice.

@nl

P1433

Q42813063-7026AC73-6629-465A-A5B2-84F0DFE1F042

P1476

Q42813063-C39E3E31-C213-4A88-AAD9-22F7C274D0DF

P2093

Q42813063-2BC17FEF-A538-4B3A-BFDE-CA5AEC5BB37E

Q42813063-35563F07-2D83-4AF3-BB8F-AC65D2FCCE17

Q42813063-490A7EF2-778D-4A85-AD4A-326D9F3197DB

Q42813063-4DA77DE5-6AF8-4DD0-B7C9-38EC33BA9976

Q42813063-50CEA524-2124-4D38-9357-9A5DF5B3283E

Q42813063-60B66222-7BB1-4B75-B76B-6A8C1BD5D475

Q42813063-6B171E76-7117-48F0-8995-2CBDF50907AD

Q42813063-7DF84657-CCEE-4865-A471-29FCAB72DEC1

Q42813063-841D8176-C912-4374-B2C6-9DF91E9472B9

Q42813063-87124AF4-39EB-48BD-AC65-09416BCF73BE

P2860

Q42813063-01ADE68E-8FA8-4782-BB11-E290CB3D520A

Q42813063-024117DB-CBF3-4953-92D6-0AB68A8B040B

Q42813063-07557BCF-65F9-48DE-A81C-9E9D1A5DC418

Q42813063-08531DB4-D478-4544-93AA-7F162018465E

Q42813063-0C723AF2-7A3A-48C9-9DF8-4F43A812BB98

Q42813063-0DAB38B6-9A04-4D03-86CE-3DCBA2A9480D

Q42813063-129A45BD-3001-4902-B5F4-DB26642357DD

Q42813063-1612B133-15C4-4275-8FF6-B260E4E64B34

Q42813063-19E8454D-D715-4788-B686-BB5C615EE60D

Q42813063-1B42E519-7531-41EB-8D1F-B027BC39DEE1

P304

Q42813063-55B5DFA3-4C7A-4D18-AAE9-BF42F9E7E573

P31

Q42813063-8A09ECA0-A98C-43BF-9291-6E8A02D969FB

P356

Q42813063-1E3DB5EA-AA18-4DD8-8DF2-FAC05ADB859D

P407

Q42813063-C3D31CFB-2155-4EFE-ABEB-6C2AC67B271C

P433

Q42813063-3DEC8CFC-EB52-4C8C-AF31-86163186C3C4

P478

Q42813063-EE7B2D2F-852A-4AC2-890E-4C3F349DDF54

P50

Q42813063-BAF69469-2739-4793-AEC4-F5A58182257E

P577

Q42813063-355552C5-2683-44FD-9966-F7938B7B05EF

P698

Q42813063-DE6C20A0-6B6D-4658-84F1-E2668A1565CD

P356

P1433

Biochemical Journal

P1476

Glucan particles for selective delivery of siRNA to phagocytic cells in mice

@en

P2093

Anca Goller

http://www.w3.org/2001/XMLSchema#string

Chang-An Guo

http://www.w3.org/2001/XMLSchema#string

Emilie Boutet

http://www.w3.org/2001/XMLSchema#string

Ernesto Soto

http://www.w3.org/2001/XMLSchema#string

Gary R Ostroff

http://www.w3.org/2001/XMLSchema#string

Gregory J Tesz

http://www.w3.org/2001/XMLSchema#string

Mark J O'Connor

http://www.w3.org/2001/XMLSchema#string

Matthieu Prot

http://www.w3.org/2001/XMLSchema#string

Mengxi Wang

http://www.w3.org/2001/XMLSchema#string

Michael P Czech

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle

Small silencing RNAs: an expanding universe

Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?

Alternative activation of macrophages

Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models

Endo-Porter: a novel reagent for safe, effective delivery of substances into cells

Efficient delivery of siRNA using dendritic poly(L-lysine) for loss-of-function analysis

Macrophages, inflammation, and insulin resistance

High efficiency lipid-based siRNA transfection of adipocytes in suspension.

A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells.

P304

351-362

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1042/BJ20110352

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

436

http://www.w3.org/2001/XMLSchema#string

P50

Joseph V Virbasius

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21418037

http://www.w3.org/2001/XMLSchema#string